PAK1 Inhibition Slows Growth and Partially Promotes Differentiation of AMKL Cells

chunling fu,chunqing wang,xueting hu,kunming qi,shujin wang,yong gao,qiong yang,wen ju,lingyu zeng,John D Crispino,qiang jeremy wen,kailin xu

DOI: https://doi.org/10.21203/rs.3.rs-363938/v1

2021-01-01

Abstract:Abstract The authors have requested that this preprint be removed from Research Square.

What problem does this paper attempt to address?

High GP73 Expression Correlates with Poor Response to Neoadjuvant Chemotherapy and Survival in Gastric Cancer: A Tissue Microarray Study

Jian Guo Shen,Jun Shen,Rong Yue Teng,Lin Bo Wang,Wen He zhao,Qin Chuan Wang

DOI: https://doi.org/10.21203/rs.3.rs-27285/v1

2020-01-01

Abstract:Abstract The authors have requested that this preprint be removed from Research Square.
3-Mercaptopyruvate Sulfurtransferase Represses Tumor Progression and Predicts Prognosis in Hepatocellular Carcinoma

Meng Li,Qi Jin,Yishu Chen,Jie Zhang,Jianguo Gao,Li Cen,Yiming Lin,Chengfu Xu,Youming Li,Chaohui Yu

DOI: https://doi.org/10.21203/rs.3.rs-531506/v1

2021-01-01

Abstract:Abstract The authors have requested that this preprint be removed from Research Square.
MiR-23b-3p Targeting NCAPG Promotes Cell Proliferation and Anti-Apoptosis By Regulating PI3K/AKT Signaling Pathway in Colorectal Cancer

Peidong Li,Jing Wen,Xiru Ren,Yu Zhou,Yuan Xue,ZaiHua Yan,Shengjie Li,Hongpeng Tian,Xuegui Tang,Guangjun Zhang

DOI: https://doi.org/10.21203/rs.3.rs-529744/v1

2021-05-26

Abstract:Abstract The authors have requested that this preprint be removed from Research Square.
[Retracted] Silencing cyclin‑dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines

Miao Deng,Jianguang Wang,Yanbin Chen,Like Zhang,Gangqiang Xie,Qipeng Liu,Ting Zhang,Pengfei Yuan,Dechun Liu

DOI: https://doi.org/10.3892/mmr.2023.13075

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the GAPDH control western blotting data shown in Fig. 1C were strikingly similar to data appearing in different form in another article written by different authors at different research institutes [Chen Y, Guo Y, Yang H, Shi G, Xu G, Shi J, Yin N and Chen D: TRIM66 overexpression contributes to osteosarcoma carcinogenesis and indicates poor survival outcome. Oncotarget 6: 23708‑23719, 2015]. Moreover, a pair of data panels showing the results from cell‑cycle experiments purportedly performed under different experimental conditions in Fig. 4A appeared to be strikingly similar. Owing to the fact that the contentious data in the above article were already under consideration for publication prior to its submission to Molecular Medicine Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 14: 1523‑1530, 2016; DOI: 10.3892/mmr.2016.5401].
[Retracted] Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1

Yi Zhou,Zhigang Ji,Weigang Yan,Zhien Zhou,Hanzhong Li,Yu Xiao

DOI: https://doi.org/10.3892/or.2024.8811

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell invasion assay data shown in Fig. 3B on p. 839 were strikingly similar to data that had already appeared in another article written by different authors at different research institutes [Mao Y, Zhang L, Yuan L, Yan M and He Y: MiR‑218 suppresses cell progression by targeting APC in cervical cancer. Int J Clin Exp Pathol: 10, 2259‑2269, 2017]. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 38: 837‑842, 2017; DOI: 10.3892/or.2017.5768].
miR-188-5p Promotes Tumor Growth by Targeting CD2AP Through PI3K/AKT/mTOR Signaling in Children with Acute Promyelocytic Leukemia [Retraction]

Wang D,Chen J,Ding Y,Kong H,You H,Zhao Y,Wei H,Liu Y

IF: 4

2023-01-01

OncoTargets and Therapy

Abstract:Wang D, Chen J, Ding Y, et al. Onco Targets Ther. 2020;13:6681–6697. We, the Editors and Publisher of OncoTargets and Therapy, have retracted the following article. Following publication of the article, concerns were raised about the duplication of images from Figures 2, 3 and 8 with images from other unrelated articles. Specifically, The image for Figure 2C, HL60 cell, mimics NC, has been duplicated with the image for Figure 3F, EC18, Vector-UCA1, from Zhu Z, Wang H, Pang Y, Hu H, Zhang H, Wang W. Exosomal long non-coding RNA UCA1 functions as growth inhibitor in esophageal cancer. Aging (Albany NY). 2020;12:20523–20539. https://doi.org/10.18632/aging.103911 (RETRACTED). The images for Figure 3C, NB4 cell, inhibitors, and HL60 cell, inhibitors NC, have been duplicated with the images for Figure 5C, A549, miR-503+PDK1 from Wei Y, Liao Y, Deng Y, Zu Y, Zhao B, Li F. MicroRNA-503 Inhibits Non-Small Cell Lung Cancer Progression By Targeting PDK1/PI3K/AKT Pathway. Onco Targets Ther. 2019;12:9005–9016. https://doi.org/10.2147/OTT.S213059 and Figure 3A, I, from Wu B, Xing C, Tao J. Upregulation of microRNA-23b-3p induced by farnesoid X receptor regulates the proliferation and apoptosis of osteosarcoma cells. J Orthop Surg Res. 2019;14:398. https://doi.org/10.1186/s13018-019-1404-6, respectively. The images for Figure 8A, Ctrl+siNC and inhibitors+siNC, have been duplicated with the images for Figure 3A, PC3, sh1, from Zhang T, Sun Y, Zheng T, Wang R, Jia D, Zhang W. MLPH Accelerates the Epithelial–Mesenchymal Transition in Prostate Cancer. Onco Targets Ther. 2020;13:701–708. https://doi.org/10.2147/OTT.S225023, and Figure 4B, A498, si-POSTN, from Jia YY, Yu Y, Li HJ. POSTN promotes proliferation and epithelial-mesenchymal transition in renal cell carcinoma through ILK/AKT/mTOR pathway. Journal of Cancer. 2021;12(14):4183–4195. https://doi.org/10.7150/jca.51253. The authors did not respond to our queries and were unable to provide an explanation for the duplicated images or provide data for the study. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors were notified of this. We have been informed in our decision-making by our editorial policies and COPE guidelines. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
Retraction Notice For: “PDK2 Promotes Chondrogenic Differentiation of Mesenchymal Stem Cells by Upregulation of Sox6 and Activation of JNK/MAPK/ERK Pathway” [braz J Med Biol Res (2017) 50(2): E5988]

H Wang,Xianghong Shan,Yongxia Qiao

DOI: https://doi.org/10.1590/1414-431x20205988retraction

2020-01-01

Brazilian Journal of Medical and Biological Research

Abstract:My research group is still conducting research on the effect of PDK2 on chondrogenic differentiation of mesenchymal stem cells.Some of the current experimental results are inconsistent with the previous results.Due to the need for further confirmation of the experimental results, in order not to mislead the readers, we request withdrawal''.Meanwhile, the Editors became aware of a denouncement
[Retracted] Isoquercitrin inhibits bladder cancer progression in vitro and in vivo by regulating the PI3K/Akt and PKC signaling pathways

Feng Chen,Xiaochi Chen,Deyong Yang,Xiangyu Che,Jianbo Wang,Xiancheng Li,Zhiwei Zhang,Qifei Wang,Wei Zheng,Lina Wang,Xuejian Wang,Xishuang Song

DOI: https://doi.org/10.3892/or.2023.8684

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the agarose gel electrophoretic bands shown in Fig. 4A for PKC were strikingly similar to bands that had already appeared in another article written by different authors at different research institutes. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 36: 165‑172, 2016; DOI: 10.3892/or.2016.4794].
[Retracted] Fangchinoline suppresses growth and metastasis of melanoma cells by inhibiting the phosphorylation of FAK

Jie Shi,Bingyu Guo,Qiang Hui,Peng Chang,Kai Tao

DOI: https://doi.org/10.3892/or.2024.8740

2024-04-23

Oncology Reports

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell migration and invasion assay data shown in Fig. 3C and D on p. 67 were strikingly similar to data appearing in different form in another pair of articles written by different authors at different research institutes, one of which (subsequently retracted) had already been published elsewhere prior to the submission of this paper to Oncology Reports, with the other having been submitted for publication at around the same time. In addition, duplications of data were identified within Fig. 3C and D, such that data which had been used to represent the results from differently performed experiments had apparently been derived from the same original source. Given that the abovementioned data had already apparently been published previously, the Editor of Oncology Reports has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they accepted the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 38: 63‐70, 2017; DOI: 10.3892/or.2017.5678]

oncology
The Sulfatide/Myb/MEF2C Axis Controls the Malignant Behaviors of Hepatocellular Carcinoma Cells by Modulating Lncay Expression

Mei Hua Chen,Bing Qi,Qian Cai,Jia Wen Sun,Li Fu,Chun Lan Kang,Ming Zhe,Xingzhong Wu

DOI: https://doi.org/10.21203/rs.3.rs-44041/v1

2020-01-01

Abstract:The authors have requested that this preprint be removed from Research Square.
[Retracted] Inhibiting Proliferation and Migration of Lung Cancer Using Small Interfering RNA Targeting on Aldo‑keto Reductase Family 1 Member B10.

Zhen Zhou,Yi Zhao,Lingping Gu,Xiaoming Niu,Shun Lu

DOI: https://doi.org/10.3892/mmr.2023.13109

IF: 3.423

2023-01-01

Molecular Medicine Reports

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that data from the cell adhesion experiment shown in Fig. 11 were strikingly similar to data appearing in different form in Fig. 6B in another article written by different authors at different research institutes [Huang Z, Li J, Du S, Tang Y, Huang L, Xiao L and Tong P: FKBP14 overexpression contributes to osteosarcoma carcinogenesis and indicates poor survival outcome. Oncotarget 7: 39872‑39884, 2016]. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Molecular Medicine Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 17: 2153‑2160, 2018; DOI: 10.3892/mmr.2017.8173].
RETRACTED: Protective Autophagy Induced by Physcion Suppresses Hepatocellular Carcinoma Cell Metastasis by Inactivating the JAK2/STAT3 Axis.

Xiaoping Pan,Chen Wang,Yan Li,Lida Zhu,Ti Zhang

DOI: https://doi.org/10.1016/j.lfs.2018.10.064

IF: 6.78

2018-01-01

Life Sciences

Abstract:This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal).This article has been retracted at the request of the Editor-in-Chief and the authors, as panels from Figure 6F appear as similar to panels from Figure 2B of the article published by Ming-Quan Gao, Hui Gao, Mei Han, Kai-Li Liu, Jian-Jun Peng and Yan-Tao Han in the American Journal of Cancer Research 7 (2017) 1501–1514 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523031/ and Figures 2E and 3E of the article published by Meizhi Wang, Hui Gao, Haijun Qu, Jing Li, Kaili Liu and Zhiwu Han in Pharmacological Reports 70 (2018) 963–971 https://doi.org/10.1016/j.pharep.2018.04.006.Also, the Vehicle panel from Figure 7E appears as similar to the Vehicle panel from Figure 3D of the article published by Bo Liu and Shuo Yu in Biomedicine & Pharmacotherapy 107 (2018) 243–253 https://doi.org/10.1016/j.biopha.2018.07.177.Figure 7E appears also as similar to Figure 6(b) of the article published by Mei Han, Hui Gao, Jing Xie, Yin-ping Yuan, Quan Yuan, Ming-quan Gao, Kai-li Liu, Xue-hong Chen, Yan-tao Han and Zhi-wu Han in Acta Pharmacologica Sinica volume 40 (2019) 666–676 https://doi.org/10.1038/s41401-018-0159-7.Moreover, panels from Figure 7F appear as similar to panels from Figure 7E of the Reference [1], Figure 6D of the Reference [2], Figure 6C of the Reference [3], Figure 8C of the Reference [4], Figure 8D of the Reference [5] and Figure 6B of the Reference [6].One of the conditions of submission of a paper for publication is that authors declare explicitly that their work is original and has not appeared in a publication elsewhere. Re-use of any data should be appropriately cited. As such this article represents a severe abuse of the scientific publishing system. The scientific community takes a very strong view on this matter and apologies are offered to readers of the journal that this was not detected during the submission process.
Up-Regulation of p53/miR-628-3p Pathway, a Novel Mechanism of Shikonin on Inhibiting Proliferation and Inducing Apoptosis of A549 and PC-9 Non–Small Cell Lung Cancer Cell Lines

Jieli Pan,Meiya Li,Fenglin Yu,Feiye Zhu,Linyan Wang,Dandan Ning,Xiaoli Hou,Fusheng Jiang

DOI: https://doi.org/10.3389/fphar.2021.766165

IF: 5.6

2021-11-16

Frontiers in Pharmacology

Abstract:Shikonin (SHK) is a pleiotropic agent with remarkable cell growth inhibition activity against various cancer types, especially non–small cell lung cancer (NSCLC), but its molecular mechanism is still unclear. Our previous study found that miR-628-3p could inhibit the growth of A549 cells and induce its apoptosis. Bioinformatics analysis predicted that miR-628-3p promoter sequence contained p53 binding sites. Considering the regulatory effect of SHK on p53, we speculate that SHK may inhibit the growth and induce apoptosis of NSCLC cells by up-regulating miR-628-3p. CCK-8 and EdU assay confirmed the inhibitory effect of SHK on A549 and PC-9 cells. Meanwhile, quantitative reverse transcription–polymerase chain reaction and Western blot showed that SHK could promote the expression of p53 and miR-628-3p in a dose-dependent manner. Overexpression of p53 or miR-628-3p can inhibit the growth and promote apoptosis of A549 and PC-9 cells, while silencing p53 or miR-628-3p has the opposite effect. Dual luciferase reporting assay and ChIP (chromatin immunoprecipitation) assay further verified the direct interaction between p53 and the promoter of miR-628-3p. Gene knockdown for p53 or miR-628-3p confirmed that SHK inhibits the growth and induces apoptosis of A549 and PC-9 cells at least partly by up-regulating p53/miR-628-3p signaling pathway. Therefore, these novel findings provide an alternative approach to target p53/miR-628-3p axis and could be used for the development of new treatment strategies for NSCLC.

pharmacology & pharmacy
Retraction Note: Inhibition effects of acridone on the growth of breast cancer cells in vivo

Y-F Xia,H-J Chu,G-F Kuang,G-J Jiang,Y-C Che

DOI: https://doi.org/10.26355/eurrev_202405_36201

Abstract:The article "Inhibition effects of acridone on the growth of breast cancer cells in vivo", by Y.-F. Xia, H.-J. Chu, G.-F. Kuang, G.-J. Jiang, Y.-C. Che, published in Eur Rev Med Pharmacol Sci 2018; 22 (8): 2356-2363-DOI: 10.26355/eurrev_201804_14827-PMID: 29762857 has been retracted by the Editor in Chief for the following reasons. Following some concerns raised on PubPeer regarding a possible overlap in Figure 2, the Editor in Chief has started an investigation to assess the validity of the results as well as possible figure manipulation. The journal investigation revealed a duplication between Figures 2B and 2C. Consequently, the Editor in Chief mistrusts the results presented and has decided to retract the article. The authors have been informed about the journal's investigation but remained unresponsive. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/14827.
Global Profiling of Proteome, Lysine Acetylome and Succinylome Identifying Silica Injuries in Mice Lung

Mingyao Wang,Jiangfeng Liu,Tiantian Zhang,Zhe Zhang,Junling Pang,Yanjiang Xing,Ying Liu,Meiyue Song,Baicun Li,Juntao Yang,Jing Wang,Chen Wang

DOI: https://doi.org/10.21203/rs.3.rs-535726/v1

2021-01-01

Abstract:The authors have requested that this preprint be removed from Research Square.
[Retracted] Schisandrin B inhibits epithelial‐mesenchymal transition and stemness of large‐cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‐κB and p38 MAPK signaling pathways

Shuping Li,Hong Wang,Ruidong Ma,Li Wang

DOI: https://doi.org/10.3892/or.2024.8761

2024-06-27

Oncology Reports

Abstract:Following the publication of the above article, a concerned reader drew to the Editor's attention that certain of the Transwell cell invasion and migration assay data featured in Figs. 2D and 5E and the wound‐healing assay data in Fig. 2A were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes that had either already been published elsewhere prior to the submission of this paper to Oncology Reports , or which under consideration for publication at around the same time. In view of the fact that certain of these data had already apparently been published prior to the submission of this article for publication, the Editor of Oncology Reports has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 45: 115, 2021; DOI: 10.3892/or.2021.8066]

oncology
[Retracted] Activation of the LKB1‐SIK1 signaling pathway inhibits the TGF‐β‐mediated epithelial‐mesenchymal transition and apoptosis resistance of ovarian carcinoma cells

Bo Hong,Jianmei Zhang,Wenlan Yang

DOI: https://doi.org/10.3892/mmr.2024.13180

IF: 3.423

2024-02-10

Molecular Medicine Reports

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell invasion and migration assay data shown in Figs. 2C and 3F were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes, which had either already been published or were under consideration for publication at around the same time. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Molecular Medicine Reports , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 17: 2837‐2844, 2018; DOI: 10.3892/mmr.2017.8229]

oncology,medicine, research & experimental
Correction: PLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3

Zhipeng Gao,Xiaojun Man,Zhenhua Li,Jianbin Bi,Xiankui Liu,Zeliang Li,Jun Li,Zhe Zhang,Chuize Kong

DOI: https://doi.org/10.1038/s41417-022-00458-1

IF: 5.854

2022-03-31

Cancer Gene Therapy

Abstract:Cancer Gene Therapy, Published online: 31 March 2022; doi:10.1038/s41417-022-00458-1Correction: PLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3

oncology,genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology
[Retracted] Knockdown of STMN1 enhances osteosarcoma cell chemosensitivity through inhibition of autophagy

Zili Wang,Rongzhen He,Hansong Xia,Yu Wei,Song Wu

DOI: https://doi.org/10.3892/ol.2024.14466

2024-05-21

Oncology Letters

Abstract:Following the publication of this article, a concerned reader has drawn to the Editor's attention that the western blotting data featured in Figs. 2D, 3B, 5A and 5C contained some strikingly similar protein bands, such that these data apparently originated from the same original source where the results from differently performed experiments were intended to have been portrayed; moreover, the GAPDH control western blotting data shown in Fig. 1B were strikingly similar to data that had already appeared in a number of previous publications written by different authors at different research institutes. Owing to the identification of the apparently overlapping protein bands in Figs. 2, 3 and 5, and given the fact that the contentious data in Fig. 1B of the above article had already been published prior to its submission to Oncology Letters , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Letters 13: 3465‐3470, 2017; DOI: 10.3892/ol.2017.5941]

oncology
PAK1 Overexpression Promotes Cell Proliferation in Cutaneous T Cell Lymphoma Via Suppression of PUMA and P21

Yimeng Wang,Xiaoguang Gu,Weiwei Li,Qian Zhang,Chunlei Zhang

DOI: https://doi.org/10.1016/j.jdermsci.2017.11.019

IF: 5.408

2018-01-01

Journal of Dermatological Science

Abstract:BACKGROUND:Cutaneous T cell lymphoma (CTCL) comprises a heterogeneous group of skin-homing T cell tumors. The small guanosine triphosphate effector p21-activated kinase 1 (PAK1) plays an important role in many fundamental cellular functions, including cell motility, proliferation, and apoptosis. The expression of PAK1 is up-regulated in several types of human cancers. However, little is known about the role of PAK1 in the pathogenesis of CTCL.OBJECTIVE:The aim of this study was to evaluate the expression pattern and underlying mechanism of PAK1 in CTCL.METHODS:Quantitative real-time polymerase chain reaction(qRT-PCR) was used to detect PAK1 mRNA expression in the peripheral blood mononuclear cells (PBMCs) of patients with CTCL. The expression of PAK1 protein in CTCL tumor tissues was determined by immunohistochemistry. CTCL cell lines were treated with a small molecule inhibitor of PAK1, p21-activated kinase inhibitor III (IPA3), at concentrations of 2, 3.5 and 5 μM for 24 h. Hut 78 and HH CTCL cells were transfected with lentiviral-based PAK1 gene knockdown vectors. We determined the effects of PAK1 knockdown on cell proliferation and apoptosis in CTCL cells by MTS assay and flow cytometry. Animal experiments were performed to investigate the effects of PAK1 knockdown on the growth of tumors in vivo. Transcriptomic sequencing was performed to detect the direct downstream targets of PAK1 silencing. Reverse transcription polymerase chain reaction and western blot analysis were applied to verify the results of the transcriptomic analysis.RESULTS:We detected PAK1 overexpression in PBMCs and skin lesions from patients with CTCL compared with benign inflammatory dermatoses (BID). Knockdown of PAK1 inhibited cell proliferation and promoted spontaneous apoptosis. In addition, the inhibitory effect of IPA3 was validated in the CTCL cell lines. Additionally, mice injected with PAK1-silenced cells presented with a decreased rate of tumor growth compared with the control groups. Moreover, the mRNA and protein expression of PUMA (BBC3) and p21 (CDKN1A) were increased in PAK1-silenced Hut 78 and HH cells.CONCLUSIONS:Our data indicated that PAK1 is upregulated in CTCL. PAK1 silencing induced apoptosis and inhibited cell growth by stimulating the expression of PUMA and p21. Thus, PAK1 may be a potential tumor marker and therapeutic target of CTCL.

PAK1 Inhibition Slows Growth and Partially Promotes Differentiation of AMKL Cells

High GP73 Expression Correlates with Poor Response to Neoadjuvant Chemotherapy and Survival in Gastric Cancer: A Tissue Microarray Study

3-Mercaptopyruvate Sulfurtransferase Represses Tumor Progression and Predicts Prognosis in Hepatocellular Carcinoma

MiR-23b-3p Targeting NCAPG Promotes Cell Proliferation and Anti-Apoptosis By Regulating PI3K/AKT Signaling Pathway in Colorectal Cancer

[Retracted] Silencing cyclin‑dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines

[Retracted] Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1

miR-188-5p Promotes Tumor Growth by Targeting CD2AP Through PI3K/AKT/mTOR Signaling in Children with Acute Promyelocytic Leukemia [Retraction]

Retraction Notice For: “PDK2 Promotes Chondrogenic Differentiation of Mesenchymal Stem Cells by Upregulation of Sox6 and Activation of JNK/MAPK/ERK Pathway” [braz J Med Biol Res (2017) 50(2): E5988]

[Retracted] Isoquercitrin inhibits bladder cancer progression in vitro and in vivo by regulating the PI3K/Akt and PKC signaling pathways

[Retracted] Fangchinoline suppresses growth and metastasis of melanoma cells by inhibiting the phosphorylation of FAK

The Sulfatide/Myb/MEF2C Axis Controls the Malignant Behaviors of Hepatocellular Carcinoma Cells by Modulating Lncay Expression

[Retracted] Inhibiting Proliferation and Migration of Lung Cancer Using Small Interfering RNA Targeting on Aldo‑keto Reductase Family 1 Member B10.

RETRACTED: Protective Autophagy Induced by Physcion Suppresses Hepatocellular Carcinoma Cell Metastasis by Inactivating the JAK2/STAT3 Axis.

Up-Regulation of p53/miR-628-3p Pathway, a Novel Mechanism of Shikonin on Inhibiting Proliferation and Inducing Apoptosis of A549 and PC-9 Non–Small Cell Lung Cancer Cell Lines

Retraction Note: Inhibition effects of acridone on the growth of breast cancer cells in vivo

Global Profiling of Proteome, Lysine Acetylome and Succinylome Identifying Silica Injuries in Mice Lung

[Retracted] Schisandrin B inhibits epithelial‐mesenchymal transition and stemness of large‐cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‐κB and p38 MAPK signaling pathways

[Retracted] Activation of the LKB1‐SIK1 signaling pathway inhibits the TGF‐β‐mediated epithelial‐mesenchymal transition and apoptosis resistance of ovarian carcinoma cells

Correction: PLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3

[Retracted] Knockdown of STMN1 enhances osteosarcoma cell chemosensitivity through inhibition of autophagy

PAK1 Overexpression Promotes Cell Proliferation in Cutaneous T Cell Lymphoma Via Suppression of PUMA and P21